Overview: Bristol-Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company's business model revolves around research and development (R&D), strategic acquisitions, and partnerships to maintain a robust pipeline of new drugs. BMS operates in various therapeutic areas, including oncology, immunology, cardiovascular, and fibrosis.
Product Portfolio: BMS has a diverse product portfolio, with key...
Opdivo (Nivolumab): Opdivo is a leading immunotherapy drug used in the treatment of various cancers, including melanoma, lung cancer, and renal cell carcinoma. It has a strong market presence due to its efficacy and broad application across multiple cancer types. The oncology market is experiencing significant growth, driven by advancements in cancer treatment and increasing incidence rates. As a result, Opdivo is classified as a 'Star' due to its high market share and substantial market growth.
Eliquis (Apixaban): Eliquis is an anticoagulant u...
Our BCG tool allows you to fill out the matrix with your own products.
It's like ChatGPT but for your university course. Ask questions about your course material and get instant answers with citations.